I think it will unfold like this over the next few weeks…
1. cdh17 first patient dosed
2. placement (at a premium) to big pharma
3. Prelim data on Advent AML trial
4. FDA approval for CLTX administration change etc
Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete, page-51
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable